Cipla Ltd.

CIPLA Share PricePharmaceuticals & Drugs

1,521

13 (0.9%)

As on December 4, 2025

Exchange Scrips: BSE500087NSECIPLAISININE059A01026

Market Cap1,23,006 Cr

P/E Ratio 23.3

Dividend Yield 0.53 %

Performance

Market performance

Open1,503.1
High1,525.7
Volumes7,26,473
Prev1,521
Low1,503.1
As on2025-12-04

Historical performance

1 Year High1,673
3 Year High1,702.05
5 Year High1,702.05
1 Year Low1,335
3 Year Low852
5 Year Low738.1

Fundamentals

Company Valuation

Market Cap
Market Cap (₹Cr)
1,23,006
Face Value
Face Value (₹)
2
P/E Ratio
P/E Ratio
23.3
Dividend Yield
Dividend Yield
0.53 %

Investment Returns

1 Year
1.3%
3 Years
36.5%
5 Years
98.3%
10 Years
135.5%

Technicals

IndicatorsValueSignal
5-DMA1,520Bullish
10-DMA1,517.23Bullish
20-DMA1,519.38Bullish
50-DMA1,534.49Bearish
100-DMA1,536.67Bearish
200-DMA1,511.51Bullish

Shareholding Pattern

FieldSep-2025Jun-2025Mar-2025Dec-2024Sep-2024
Promoters44446
Foreign Investors22222
Domestic Investors22224
Public Investors534582549650543415525109470227
Government32222

Financials

Below figures are in Rs. Crores

Balance Sheet

Below figures are in Rs. Crores

Cash Flow

Below figures are in Rs. Crores

0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 23.3.
  • 3Y Stock Price CAGR of the stock is 10.9.
  • The stock has a beta of 0.9.
  • In the last financial year, the company had an EBITDA of ₹79898 Million.
  • The company generated revenue of ₹275476 Million in the previous financial year.

Cipla Ltd.

152113   (0.9%)

Investment Amount: ₹ 1000000
Current Value: ₹ 1015184.4
No. of Shares: 667 (Approx)
Performance:1.5%
P/L: ₹15184.4

Top Gainers

SymbolChange%
SMCGLOBAL73.48(20%)
MAGNUM24.77(19%)
TOTAL86.05(17%)
NECLIFE20.94(17%)
ELDEHSG951(14%)

Top Losers

SymbolChange%
EMMVEE219.86(-9%)
POWERINDIA20085(-8%)
DAVANGERE3.87(-8%)
ONMOBILE58.3(-7%)
DUCON3.67(-7%)
BEDMUTHA101.23(-7%)
AVG176.08(-6%)
KAYNES4978(-6%)

Peer Comparison

Venus Remedies Ltd.

72.4%

764.15

1 Month Performance

Nectar Lifesciences Ltd.

49.5%

20.94

1 Month Performance

Ortin Global Ltd.

26.9%

14.49

1 Month Performance

Natco Pharma Ltd.

15.8%

949.25

1 Month Performance

SMS Pharmaceuticals Ltd.

14.8%

322.45

1 Month Performance

Ipca Laboratories Ltd.

12.3%

1454.6

1 Month Performance

Haleos Labs Ltd.

11.4%

1315.1

1 Month Performance

Gufic Biosciences Ltd.

9.5%

358.15

1 Month Performance

Get Your Portfolio Reviewed

Stock of the Month
Stock of the Month